https://investingnews.com/mydecine-innovations-group-inc-announces-closing-of-share-for-debt-settlement/
Mydecine Innovations Group Inc. Announces Closing of Share for Debt Settlement | INN
Mar 28, 2024 - (TheNewswire) V ANCOUVER, BC ( TheNewswire 27 March 2024 ) MYDECINE INNOVATIONS GROUP INC . (CSE: MYCO) (AQSE: MYIG) (FSE: 0NFA) (OTC: MYCOF) (the " Company "...
mydecine innovations group
https://www.globenewswire.com/news-release/2020/12/08/2141227/0/en/Mydecine-Innovations-Group-to-Make-First-Commercial-Export-of-Legal-Psilocybin-Mushrooms.html
Mydecine Innovations Group to Make First Commercial Export
Mydecine completes harvest and is preparing to export 20 kilograms of psilocybin mushrooms from Jamaica to Canada for increased global supply scale of cGMP...
mydecine innovations groupto makefirstcommercialexport
https://investingnews.com/mydecine-provides-q4-2023-business-update/
Mydecine Provides Q4 2023 Business Update | INN
Oct 26, 2023 - MYDECINE INNOVATIONS GROUP INC. ("Mydecine" or the "Company") (CSE:MYCO) (AQSE:MYIG) (OTC:MYCOF) (FSE:0NFA), a biotechnology company engineering the next wave...
q4 2023business updatemydecineprovidesinn
https://investingnews.com/mydecine-reports-its-2023-annual-general-shareholders-meeting-results/
Mydecine Reports its 2023 Annual General Shareholders' Meeting Results | INN
May 11, 2023 - MYDECINE INNOVATIONS GROUP INC. ("Mydecine" or the "Company") (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA), a biotechnology company engineering the next wave of...
general shareholders meeting2023 annualmydecinereportsresults
https://www.ig.com/it-ch/azioni/mercati-azioni/mydecine-innovations-group-inc
Trading Azioni Mydecine Innovations Group Inc | Prezzo Azioni Mydecine Innovations Group Inc | IG...
Consulta i dettagli di mercato sulle azioni Mydecine Innovations Group Inc. Analisi, prezzo e altre informazioni per fare trading sulle azioni... [IT-CH]
mydecine innovations grouptradingazioniincprezzo
https://www.benzinga.com/markets/cannabis/22/04/26422012/mydecine-reports-financial-results-for-2021
Mydecine Reports Financial Results For 2021 - NOVERIS HEALTH SCIENCES by Noveris Health Sciences...
financial resultshealth sciencesmydecinereports2021
https://www.ig.com/de/aktien/maerkte-aktien/mydecine-innovations-group-inc
Mydecine Innovations Group Inc Aktien handeln | Mydecine Innovations Group Inc Realtime Aktienkurs...
Mydecine Innovations Group Inc [DE]
mydecine innovations groupincaktienhandelnrealtime
https://www.businesswire.com/news/home/20210323005158/en/Mydecine-Innovations-Group-Graduates-Listing-To-NEO-Exchange
Mydecine Innovations Group Graduates Listing To NEO Exchange
Mydecine Innovations Group (NEO:MYCO), a psychedelics-inspired biotech and life sciences company, is now trading on NEO.
mydecine innovations groupgraduateslistingneoexchange
https://mydecine.com/
Home - Mydecine
May 6, 2026 - edit post Physical Health How Holle Formula Supports Healthy Growth and High Nutrition for Babies edit post Preventive Care From
mydecine
https://www.biospace.com/mydecine-fully-completes-the-first-ever-international-export-of-psilocybin-mushrooms-and-solidifies-its-clinical-and-commercial-supply-chain
Mydecine Fully Completes the First-Ever International Export of Psilocybin Mushrooms and Solidifies...
Mar 2, 2021 - Mydecine Innovations Group, an emerging biopharma company in the life sciences category committed to the research and development, production, and acceptance...
https://investingnews.com/news/psychedelics-investing/mydecine-innovations-group-appoints-josephine-wu-to-board-of-directors/
Mydecine Innovations Group Appoints Josephine Wu to Board of Directors | INN
Jan 10, 2022 - Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company'), an emerging biopharma and life sciences company committed to the...
mydecine innovations groupboard of directorsjosephine wuappoints